Deutsche Bank
NVO

Deutsche Bank’s Novo Nordisk NVO Stock Holding History

Deutsche Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,510
Closed -$2K – 5676
2013
Q2 		$2K Buy
+10,510
New +$175K ﹤0.01% 5175

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Deutsche Bank's NVO Position: Q1 2026 in Review

Deutsche Bank reduced its Novo Nordisk (NVO) stake by 77% in Q1 2026, selling an estimated $18.4M and leaving 113,321 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Deutsche Bank first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $65.4M in Q2 2023. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Deutsche Bank held 113,321 shares of Novo Nordisk worth $4.16M as of Q1 2026.
  • Deutsche Bank sold 388,518 Novo Nordisk shares in Q1 2026, an estimated $18.4M.
  • Novo Nordisk made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1392 holding.
  • Deutsche Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Novo Nordisk position peaked at $65.4M in Q2 2023.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.